<DOC>
	<DOCNO>NCT02941510</DOCNO>
	<brief_summary>A randomized , double-blinded study administer budesonide , medication reduce inflammation lung , healthy volunteer examine effect altitude illness prevention spending 18 hour overnight 14,000 ft elevation .</brief_summary>
	<brief_title>Inhaled Budesonide Altitude Illness Prevention</brief_title>
	<detailed_description>A randomized , double-blinded study conduct validate result previous literature use budesonide prevention altitude sickness . It conduct use healthy participant overseen experienced wilderness medicine altitude researcher Altitude Research Center University Colorado Denver . Participants recruit Denver community prescreened eligibility via phone . 100 participant , consent , baseline data blood collect begin budesonide therapy 72 hour prior take Denver Pikes Peak , observe altitude 18 hour . Patients opportunity withdraw consent time monitor continuously physician-researchers . Data collection blood draw perform specific time point analyze efficacy budesonide vs. placebo incidence altitude sickness .</detailed_description>
	<mesh_term>Altitude Sickness</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>healthy , altitude naive , 2140 year old smoker pregnancy hx asthma current inhale steroid use diseases disorder know affected hypoxia drug use study migraine chronic headache , sickle cell trait disease , diabetes history significant head injury seizures take medication ( overthecounter prescription ) herbal supplement know hypersensitivity reaction budesonide inability headachefree consume amount caffeine two six ounce cup coffee less per day exposure high altitude 2000m previous 1 month airline flight six hour ( Airplane cabin pressurize elevation approximate exposure high altitude )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>